<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://upnexhealth.com/2026/07/31/peptide-therapy-fda-compounding-patient-safety/</loc><news:news><news:publication><news:name>UPNEX HEALTH</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-31T13:19:17+00:00</news:publication_date><news:title>Peptide Therapy Is Having a Regulatory Moment. Here’s What Patients Should Know Before the Hype Gets Louder</news:title><news:keywords>patient safety, telehealth, FDA, Patient Education, Biohacking, Wellness Industry, MOTs-C, Compounded Drugs, BPC-157, Semax, Drug Compounding, Business of Healthcare, Med Spas, TB-500, Peptide Therapy, Peptides, KPV, Epitalon, peptide therapy FDA, FDA peptide vote, compounded peptides, wellness clinics, peptide therapy risks, peptide safety</news:keywords></news:news><image:image><image:loc>https://upnexhealth.com/wp-content/uploads/2026/07/chatgpt-image-jul-31-2026-09_13_45-am.png?w=150</image:loc></image:image></url></urlset>
